|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Adenoscan (Adenosine) Injection, Fujisawa Healthcare, NDA 20-059/S7 8/31/01 11/5/01 11/5/01 11/7/01
Adenoscan Indications: Adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately.
Adenosine Injection, 3 mg/mL, Sicor ANDA 76-564 9/23/03
Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-500 5/14/03
Adenosine Injection, 3 mg/mL, Baxter Healthcare ANDA 76-501 5/14/03
Adenosine Injection, 3 mg/mL, 2 mL & 4 mL, Bedford ANDA 76-404 | Adenosine Injection, American Pharma, Approval | Adenocard (adenosine) Injection, Astellas Pharma, Labeling Revision | Adenoscan (adenosine) Injection, Astellas Pharma, Labeling Revision | Adenosine Injection, Sicor Pharma, Tentative Approval | Adenosine Injection, Abraxis Pharma, Tentative Approval
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|